GlassScriptPhysician profile
Luis Ortiz Munoz
NPI 1568563401
$10,536.38
in general payments reported to CMS, 2019-2025
34 companies · $1,385 in 2025
The $1,385 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,939 · 2020: $654 · 2021: $1,633 · 2022: $1,699 · 2023: $1,603 · 2024: $1,624 · 2025: $1,385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,565 · Education: $46.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,564.50 |
| Education | $46.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,195.17 | 2019-2025 | Eliquis, Camzyos |
| Amgen INC. | $1,153.34 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $962.25 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $880.16 | 2019-2023 | Lifevest |
| Amarin Pharma, INC. | $783.68 | 2019-2023 | |
| Abbott Laboratories | $756.78 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $639.45 | 2019-2024 | Xarelto |
| Pfizer INC. | $633.95 | 2019-2025 | |
| Edwards Lifesciences Corporation | $403.82 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Astrazeneca Pharmaceuticals LP | $388.79 | 2019-2025 | Farxiga, Wainua |
| Heartflow, INC. | $327.75 | 2023-2025 | Ffrct |
| Sanofi-Aventis U.S. LLC | $286.05 | 2019-2024 | |
| Novo Nordisk INC | $237.60 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Impulse Dynamics (USA) INC. | $234.91 | 2022-2025 | Optimizer, Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $217.91 | 2022-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $183.98 | 2022-2024 | Watchman Flx |
| Medtronic Vascular, INC. | $157.46 | 2019 | |
| Astellas Pharma US INC | $139.70 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $113.80 | 2024 | Arcalyst |
| Atricure, INC. | $103.18 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $95.41 | 2023-2024 | Inpefa |
| Kestra Medical Technology Services, INC. | $84.74 | 2023-2024 | Assure Wcd |
| Kiniksa Pharmaceuticals, LTD. | $77.78 | 2022-2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.91 | 2023-2025 | Jardiance |
| Arbor Pharmaceuticals, INC. | $68.57 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $67.00 | 2019 | |
| Esperion Therapeutics, INC. | $40.88 | 2020-2024 | Nexletol |
| Merck Sharp & Dohme LLC | $39.66 | 2023 | Verquvo |
| Scpharmaceuticals INC. | $37.90 | 2025 | |
| Lilly USA, LLC | $33.30 | 2022-2025 | Mounjaro, Zepbound |
| Allergan, INC. | $31.85 | 2019 | |
| Bridgebio Pharma, INC. | $31.18 | 2025 | Attruby |
| Alnylam Pharmaceuticals INC. | $28.41 | 2024 | Onpattro |
| Kowa Pharmaceuticals America, INC. | $23.06 | 2024 | Livalo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Ortiz Munoz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.